Simplex Trading’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Sell |
30,700
-94,300
| -75% | -$2.81M | ﹤0.01% | 2482 |
|
|
2025
Q4 | $3.73M | Sell |
125,000
-30,500
| -20% | -$996K | ﹤0.01% | 1497 |
|
|
2025
Q3 | $5.62M | Buy |
155,500
+32,900
| +27% | +$1.08M | ﹤0.01% | 1362 |
|
|
2025
Q2 | $4.41M | Sell |
122,600
-80,300
| -40% | -$2.99M | ﹤0.01% | 1452 |
|
|
2025
Q1 | $8M | Sell |
202,900
-129,100
| -39% | -$4.34M | 0.01% | 1017 |
|
|
2024
Q4 | $9.99M | Buy |
332,000
+188,500
| +131% | +$5.41M | 0.01% | 1033 |
|
|
2024
Q3 | $3.36M | Sell |
143,500
-74,800
| -34% | -$1.63M | ﹤0.01% | 1832 |
|
|
2024
Q2 | $3.88M | Sell |
218,300
-144,900
| -40% | -$2.31M | ﹤0.01% | 1621 |
|
|
2024
Q1 | $5.52M | Buy |
363,200
+66,900
| +23% | +$1.07M | ﹤0.01% | 1534 |
|
|
2023
Q4 | $5.06M | Buy |
296,300
+135,900
| +85% | +$1.58M | ﹤0.01% | 1538 |
|
|
2023
Q3 | $1.34M | Buy |
160,400
+59,200
| +58% | +$825K | ﹤0.01% | 2409 |
|
|
2023
Q2 | $2.51M | Buy |
101,200
+47,900
| +90% | +$1.24M | ﹤0.01% | 1790 |
|
|
2023
Q1 | $801K | Sell |
53,300
-249,200
| -82% | -$3.79M | ﹤0.01% | 2798 |
|
|
2022
Q4 | $3.58M | Buy |
302,500
+163,900
| +118% | +$1.19M | ﹤0.01% | 1436 |
|
|
2022
Q3 | $820K | Sell |
138,600
-42,900
| -24% | -$281K | ﹤0.01% | 2883 |
|
|
2022
Q2 | $771K | Buy |
181,500
+53,800
| +42% | +$336K | ﹤0.01% | 2924 |
|
|
2022
Q1 | $1.21M | Buy |
127,700
+88,300
| +224% | +$1.02M | ﹤0.01% | 2679 |
|
|
2021
Q4 | $748K | Buy |
39,400
+13,400
| +52% | +$348K | ﹤0.01% | 3267 |
|
|
2021
Q3 | $1.05M | Buy |
26,000
+200
| +0.8% | +$6.19K | ﹤0.01% | 2991 |
|
|
2021
Q2 | $1M | Buy |
+25,800
| New | +$1.01M | ﹤0.01% | 3126 |
|
|
2021
Q1 | – | Sell |
-1,104
| Closed | -$5.74M | – | 10020 |
|
|
2020
Q4 | $5.74M | Buy |
1,104
+599
| +119% | +$20.2K | 0.01% | 895 |
|
|
2020
Q3 | $1.35M | Sell |
505
-216
| -30% | -$4.97K | ﹤0.01% | 1907 |
|
|
2020
Q2 | $1.4M | Sell |
721
-54
| -7% | -$870 | ﹤0.01% | 1819 |
|
|
2020
Q1 | $762K | Buy |
775
+320
| +70% | +$4.04K | ﹤0.01% | 2146 |
|
|
2019
Q4 | $505K | Buy |
455
+180
| +65% | +$1.37K | ﹤0.01% | 2745 |
|
|
2019
Q3 | $154K | Buy |
275
+58
| +27% | +$404 | ﹤0.01% | 3845 |
|
|
2019
Q2 | $187K | Sell |
217
-195
| -47% | -$1.47K | ﹤0.01% | 3528 |
|
|
2019
Q1 | $331K | Sell |
412
-138
| -25% | -$746 | ﹤0.01% | 3095 |
|
|
2018
Q4 | $225K | Sell |
550
-443
| -45% | -$2.2K | ﹤0.01% | 3033 |
|
|
2018
Q3 | $556K | Buy |
993
+950
| +2,209% | +$10.9K | ﹤0.01% | 2522 |
|
|
2018
Q2 | $56K | Sell |
43
-97
| -69% | -$1.33K | ﹤0.01% | 4935 |
|
|
2018
Q1 | $27K | Buy |
140
+9
| +7% | +$115 | ﹤0.01% | 3064 |
|
|
2017
Q4 | $23K | Sell |
131
-371
| -74% | -$3.24K | ﹤0.01% | 3186 |
|
|
2017
Q3 | $31K | Buy |
502
+122
| +32% | +$1.39K | ﹤0.01% | 2758 |
|
|
2017
Q2 | $33K | Sell |
380
-264
| -41% | -$2.96K | ﹤0.01% | 2793 |
|
|
2017
Q1 | $25K | Buy |
644
+626
| +3,478% | +$4.49K | ﹤0.01% | 3034 |
|
|
2016
Q4 | $1K | Buy |
+18
| New | +$106 | ﹤0.01% | 5517 |
|
|
2016
Q1 | – | Sell |
-111
| Closed | -$23K | – | 6236 |
|
|
2015
Q4 | $23K | Sell |
111
-20
| -15% | -$253 | ﹤0.01% | 2570 |
|
|
2015
Q3 | $26K | Buy |
+131
| New | +$1.95K | ﹤0.01% | 2546 |
|
|
2015
Q2 | – | Sell |
-27
| Closed | -$5K | – | 5852 |
|
|
2015
Q1 | $5K | Sell |
27
-18
| -40% | -$273 | ﹤0.01% | 3542 |
|
|
2014
Q4 | $8K | Buy |
+45
| New | +$586 | ﹤0.01% | 2763 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
Simplex Trading's TGTX Position: Q1 2026 in Review
Simplex Trading reduced its TG Therapeutics (TGTX) stake by 85% in Q1 2026, selling an estimated $1.04M and leaving 6,069 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #4286.
Simplex Trading first reported a position in TGTX in Q4 2014 and has held it in 38 quarters since. The position peaked at $5.42M in Q4 2024. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Simplex Trading held 6,069 shares of TG Therapeutics worth $202K as of Q1 2026.
- Simplex Trading sold 34,973 TG Therapeutics shares in Q1 2026, an estimated $1.04M.
- TG Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4286 holding.
- Simplex Trading first reported a position in TG Therapeutics in Q4 2014 and has held it in 38 quarters since.
- Simplex Trading's TG Therapeutics position peaked at $5.42M in Q4 2024.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.